Clinical Trials Logo

Dry Socket clinical trials

View clinical trials related to Dry Socket.

Filter by:

NCT ID: NCT05984173 Completed - Dry Socket Clinical Trials

Role of Vitamin E in Reducing Dry Socket

Start date: January 1, 2022
Phase: Phase 4
Study type: Interventional

90 female patients seeking extraction of a single tooth in the lower posterior region were divided randomly into 45 patients received vitamin E inside the socket after extraction (study group) and 45 patients didn't receive vitamin E after extraction (control group).

NCT ID: NCT05875506 Recruiting - Dry Socket Clinical Trials

Efficacy of Ozone Gel, Doxycycline Saturated Chitosan Dressing Versus Alveogyl in Pain Alleviation and Healing of Alveolar Osteitis

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

Efficacy of ozone gel, doxycycline saturated chitosan dressing versus Alveogyl in pain alleviation and healing of alveolar osteitis in diabetic patients

NCT ID: NCT05850650 Not yet recruiting - Alveolar Osteitis Clinical Trials

The Effect of Post-extraction Collagen Sponge Application on Alveolar Osteitis

Start date: May 1, 2023
Phase: Phase 2
Study type: Interventional

The goal of this randomized controlled trial is to compare pain, mouth opening, and alveolar osteitis following surgical extraction of bilateral symmetrical impacted lower third molars using two types of wound closures. Collagen plugs will be applied in the sockets of the study side followed by suture, while the controlled side will be sutured without a collagen plug. The study will include 40 patients aged between 18- 40 years old, medically fit (ASA1), who have bilateral symmetrical impacted lower third molars and visit the oral surgery clinics of King Saud Medical City for extraction. The main question is" Does intra-alveolar collagen application after surgical extraction of impacted lower third molars reduce the incidence of alveolar osteitis?

NCT ID: NCT05615272 Recruiting - Pain Clinical Trials

Treatment of Alveolar Osteitis: Traditional or Regenerative?

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Alveolar osteitis, commonly referred to as dry socket, is a common painful postoperative complication following tooth extraction. It is defined as pain in and around an extraction socket which increases at any time between one and three days following extraction, accompanied by partial or total loss of the blood clot from the socket, with or without halitosis (Blum, 2002). The incidence of the complication varies from 1-5% for routine extractions up to approximately 30% for third molar extractions. There are a variety of factors that contribute to the incidence of dry socket including tissue trauma, smoking in the early postoperative period and the oral contraceptive pill. Although it is a self- limiting condition, symptoms can be very debilitating for patients and therefore following diagnosis, immediate treatment should be provided to expedite resolution and to their improve quality of life during the healing period. Treatment options for dry socket vary from rinsing of the socket, regular analgesia and sometimes placement of an obtundent, sedative dressing such as Alveogyl or a zinc oxide eugenol alternative. This study will aim to compare two treatments for patients who present with alveolar osteitis (dry socket) to Dublin Dental University Hospital after tooth extraction. Following randomisation, one of two treatment modalities will be used, either a experimental treatment (Bio-PRF) or a positive control (Alveogyl). The results of this study will enable us to learn more about the efficacy of these treatment options for dry socket and how they affect patients.

NCT ID: NCT05536115 Recruiting - Dry Socket Clinical Trials

Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket

Start date: December 13, 2022
Phase:
Study type: Observational

Alveogyl (Septodont, Saint-Maur-des-Fossés - France) is a Medical Device used as dressing in case of dry socket. ALVE study is a clinical investigation measuring Alveogyl performance and safety in patients with post-extraction dry socket. The study takes place in India and in France where Alveogyl is already marketed, since 2010 in France and since 2014 in India .

NCT ID: NCT04853589 Recruiting - Alveolar Osteitis Clinical Trials

Effect of Hyaluronic Acid on the Therapy of Alveolar Osteitis

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Alveolar osteitis (AO; syn. dry socket) is one of the most frequent complications following tooth removal and it is defined as presence of severe postoperative pain in and around the extraction site, which increases in severity at any time between one and three days after extraction, accompanied by a partially or completely disintegrated blood cloth within the alveolar socket, with or without halitosis, and at the same time excluding any other cause for the pain (Blum 2002). To enhance standard treatment of AO, which consists of curettage of the dry socket, rinsing with saline solution, and inducing bleeding from the exposed alveolar bone walls, numerous products have been tested. One of them is hyaluronic acid (HY). The aim of the present study is to investigate the potential effect of HY gel application in the treatment of AO. Specifically, the application of HY only (HY test group; n = 20) or the combination of HY and an absorbable collagen sponge (HY+C test group; n = 20) will be compared to standard treatment (blood clot; control group, n=20). Clinical and patient related outcome parameters will be recorded for up to 14 days after treatment. A more stable blood clot and thus improved wound healing with faster pain reduction is expected through the use of HY.

NCT ID: NCT04507009 Completed - Alveolar Osteitis Clinical Trials

Clinical Investigation of the Efficacy of CGF and Ozone in the Treatment of Alveolar Osteitis

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the efficacy of CGF and Ozone in the treatment of alveolitis and to develop a new treatment protocol that can enable a quick and effective solution of this clinical problem, which significantly affects patients' comfort of life.

NCT ID: NCT04476121 Enrolling by invitation - Alveolar Osteitis Clinical Trials

Use of PRF in Treatment of Dry Socket.

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate the influence of PRF application in case of alveolar osteitis.

NCT ID: NCT04151147 Completed - Alveolar Osteitis Clinical Trials

Effect of CGF on Frequency of Alveolar Osteitis Following Partially Erupted Mandibular Third Molar Surgery

Start date: January 2, 2018
Phase: N/A
Study type: Interventional

The aim of this prospective study was to assess the effectiveness of concentrated growth factors (CGFs) in preventing the development of alveolar osteitis (AO) after the extraction of partially-erupted mandibular third molars. This study was designed as a randomized controlled clinical trial. In each case, one socket received CGFs and the other served as a control. The predictor variable was the CGFs application and the sides were categorized as 'CGFs' and 'non-CGFs'. The outcome variable was the development of AO during the first postoperative week. Also, demographic variable included age and gender was noted.

NCT ID: NCT04091399 Completed - Alveolar Osteitis Clinical Trials

First-in-man Study of Adult Patients Suffered From Alveolar Osteitis Treated Using Stomatological Tamponade Contipro

Start date: September 11, 2015
Phase: Phase 2
Study type: Interventional

Alveolar Osteitis (AO) is a complication following extraction of a tooth. AO manifests by localized pain in and around the extraction site where the postoperative blood clot has been disintegrated. The aim of this study was to determinate if there are any concerns of use of a pharmacological drug composed of an octenidine and lyophilized hyaluronic acid in a treatment of AO. The tested drug is a sponge-like material composed solely of fully absorbable medicaments. It was designed to serve as non-toxic, slow-dissolving antiseptic which adheres to mucosa and so obturate the wound. The treatment was considered effective when the pain subsided to < 20mm VAS in < 8 days of treatment.